ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Advaxis cuts staff as it seeks partner for troubled cancer vaccine
fiercebiotech
June 11, 2018Just six weeks after taking the helm of biotech Advaxis, CEO Ken Berlin has launched a search for a partner for its stalled lead axalimogene filolisbac (AXAL) and will scale back trials of the immunotherapy in order to bring earlier stage programs forward -
New leadership at Advaxis
biospectrumasia
April 25, 2018Kenneth A. Berlin appointed President, CEO and Director; Dr. Andres A. Gutierrez named Chief Medical Officer; Sara Bonstein, CFO, to depart -
FDA Halts Advaxis Study Following Patient Death
biospace
March 14, 2018Shares of?Advaxis, Inc.?announced that the U.S. Food and Drug Administration?halted a Phase I/II trial?that uses an?AstraZeneca Pharmaceuticals LPdrug following the death of a patient.
Pharma Sources Insight July 2025
